Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis

ACS Appl Mater Interfaces. 2014 Dec 24;6(24):21859-73. doi: 10.1021/am5036225. Epub 2014 Jul 22.

Abstract

Nanotheranostics is a relatively new, fast-growing field that combines the advantages of treatment and diagnosis via a single nanoscale carrier. The ability to bundle both therapeutic and diagnostic capabilities into one package offers exciting prospects for the development of novel nanomedicine. Nanotheranostics can deliver treatment while simultaneously monitoring therapy response in real-time, thereby decreasing the potential of over- or under-dosing patients. Polymer-based nanomaterials, in particular, have been used extensively as carriers for both therapeutic and bioimaging agents and thus hold great promise for the construction of multifunctional theranostic formulations. Herein, we review recent advances in polymer-based systems for nanotheranostics, with a particular focus on their applications in cancer research. We summarize the use of polymer nanomaterials for drug delivery, gene delivery, and photodynamic therapy, combined with imaging agents for magnetic resonance imaging, radionuclide imaging, and fluorescence imaging.

Keywords: cancer; drug delivery; imaging; nanoparticle; polymer; theranostics.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Drug Carriers
  • Magnetic Resonance Imaging
  • Mice
  • Nanotechnology*
  • Neoplasms / diagnosis*
  • Neoplasms / therapy*
  • Polymers / chemistry*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Polymers